Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Human risk identified in new H3N2 in Denmark

This article was originally published in Clinica

Executive Summary

The need for continued surveillance of the evolution or emergence of influenza viruses has been highlighted again in Europe with the discovery of a new strain of H3N2. The results of tests on an outbreak of influenza on mink farms in Denmark have led to the conclusion that the "novel human-animal reassortant" is "likely to be a novel swine influenza virus" with potential to infect humans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel